Parkinson's Disease Treatment Market Size, Key Players, Future Growth Opportunities by 2026

According to IMARC Group's latest report, titled "Parkinson's Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global parkinson's disease treatment market is expected to grow at a CAGR of around 6% during 2021-2026. Parkinson's disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa medicines.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a PDF sample of this report: https://www.imarcgroup.com/parkinsons-disease-treatment-market/requestsample

Market Trends and Drivers:

The parkinson's disease treatment market is primarily driven by the steadily increasing number of patients suffering from Parkinson's disease on the global level. Along with this, a considerable rise in the geriatric population that is more prone to develop neurodegenerative ailments is expected to provide a thrust to the market growth. Moreover, continual developments in gene therapy, neurostimulation tools, and neural transplantation procedures are anticipated to create a positive outlook for the market. Some of the other factors contributing to the market growth include rising awareness regarding efficient treatment options and significant improvements in the healthcare infrastructure.

Parkinson's Disease Treatment Market Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the parkinson's disease treatment market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

AbbVie Inc.
Acadia Pharmaceuticals Inc.
Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
H. Lundbeck A/S
Merck & Co. Inc.
Mylan N.V.
Novartis AG
Orion Corporation
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries
Wockhardt Ltd.

Key Market Segmentation:

The report has segmented the global parkinson's disease treatment market on the basis of region, drug class, administration and distribution channel.

Breakup by Drug Class:

Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO Inhibitors
COMT Inhibitors
Anticholinergics
Others

Breakup by Route of Administration:

Oral
Transdermal
Subcutaneous
Intestinal Infusion
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2792&flag=C

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.